One of the most dreaded feelings for an investor is when the stock they just bought is overvalued, or they missed out on an undervalued opportunity by not acting fast enough.

But what if you had the insights to effectively evaluate a company like Amedisys Inc before investing? Investing requires a certain perspective to avoid being overly confident in a company or worried about cyclical changes. A smart way to take the guesswork out of knowing when to buy or sell Amedisys Inc’s stock is to have the right tools and resources as well as a clear monitoring process.

In this article, we go over a few key elements for understanding Amedisys Inc’s stock price such as:

• Current stock price and volume
• Stock price history
• Upgrades and downgrades from analysts
• Stock price momentum as measured by its relative strength

About Amedisys Inc (AMED)

Before we jump into Amedisys Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Amedisys, Inc. is a healthcare services company that provides care and support in the home. The Company's operations involve serving patients through its four operating divisions: home health, hospice, personal care, and high acuity care. The home health segment provides healthcare to help its patients recover from surgery or illness, live with chronic diseases and prevent avoidable hospital readmissions. The segment provides care teams that consists of skilled nurses, care for wounds, monitor vital signs and provide a range of other nursing services. The Hospice segment provides comfort and support for customers who are dealing with a terminal illness. The Personal Care segment provides patients with assistance with the essential activities of daily living. Its high acuity care segment delivers the essential elements of inpatient hospital and skilled nursing facility (SNF) care to patients in their homes. The Company owns and operates approximately 532 care centers in 37 states.

Want to learn more about Amedisys Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Amedisys Inc. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips.

Amedisys Inc’s Stock Price as of Market Close

As of May 09, 2023, 4:00 PM CST, Amedisys Inc’s stock price was $76.97.

Amedisys Inc is down 4.19% from its previous closing price of $80.34.

During the last market session, Amedisys Inc’s stock traded between $77.37 and $81.10. Currently, there are 32.56 million shares of Amedisys Inc stock available for purchase.

Amedisys Inc’s price-earnings (P/E) ratio is currently at 23.4, which is high compared to the Healthcare Facilities & Services industry median of 22.8. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Amedisys Inc Stock Price History

Amedisys Inc’s (AMED) price is currently down 4.15% so far this month.

During the month of May, Amedisys Inc’s stock price has reached a high of $85.81 and a low of $73.49.

Over the last year, Amedisys Inc has hit prices as high as $131.32 and as low as $69.37. Year to date, Amedisys Inc’s stock is down 52.45%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Amedisys Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 08, 2023, there were 7 analysts who downgraded Amedisys Inc’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Amedisys Inc’s financial health and valuation. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others.

Therefore, AAII developed a composite valuation to help resolve such issues. AAII’s Value Grade analyzes six distinct variables: price-to-sales (P/S) ratio, price-earnings (P/E) ratio, the ratio of enterprise value to earnings before interest, taxes, depreciation and amortization (EV/EBITDA), shareholder yield, price-to-book-value (P/B) ratio and price-to-free-cash-flow (P/FCF) ratio.

Amedisys Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Amedisys Inc (AMED) by visiting AAII Stock Evaluator.

Relative Price Strength of Amedisys Inc

Relative price strength addresses the relationship between a stock price’s trend and the price trend of the market. This ratio is expressed as a percentage and helps investors understand a company’s momentum as well as its value. You can use relative price strength to select investments that have been outperforming the market or a specific benchmark.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. The weighted four-quarter relative price strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40%, and each of the three previous quarters are given a weighting of 20%.

As of May 08, 2023, Amedisys Inc has a weighted four-quarter relative price strength of -9.09%, which translates to a Momentum Score of 36 and is considered to be Weak.

Want to learn more about how Amedisys Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Amedisys Inc Stock Price: Bottom Line

As of May 9, 2023, Amedisys Inc’s stock price is $76.97, which is down 4.19% from its previous closing price.

At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and analytics before making a decision. Whether you decide it’s a good time to buy or sell Amedisys Inc’s stock based on its stock price forecast is ultimately up to you.

It’s important to understand that stock prices are driven by a variety of factors, but ultimately the price at any given moment is due to the supply and demand in the market. Stock price overviews, like the one you just read, only give you a small snapshot of a company’s performance, value and momentum.

By becoming an A+ Investor subscriber, you will have full access to analytics, grades, stock screens, commentary and more so you can invest with confidence.